Rutgers Racing to Discover a Better Paxlovid
March 29, 2024
March 29, 2024
NEW BRUNSWICK, New Jersey, March 29 (TNSres) -- Rutgers University issued the following news:
* * *
SARS-CoV-2 will eventually become resistant to the only effective oral treatment. The world needs another.
* * *
By Andrew Smith
Researchers from Rutgers Health believe they are among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid - an antiviral medication that helps keep high-risk patients . . .
* * *
SARS-CoV-2 will eventually become resistant to the only effective oral treatment. The world needs another.
* * *
By Andrew Smith
Researchers from Rutgers Health believe they are among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid - an antiviral medication that helps keep high-risk patients . . .